Oscar Health (NYSE:OSCR) Sets New 1-Year High – What’s Next?

Shares of Oscar Health, Inc. (NYSE:OSCR) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $30.66 and last traded at $29.53, with a volume of 1130498 shares. The stock had previously closed at $29.79.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and raised their target price for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. UBS Group increased their price objective on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Weiss Ratings downgraded shares of Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday. Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Finally, Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Three analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Oscar Health has an average rating of “Hold” and a consensus price target of $20.78.

Oscar Health Trading Down 2.1%

The stock has a 50 day moving average of $23.03 and a 200-day moving average of $17.37. The company has a market capitalization of $8.79 billion, a P/E ratio of -49.42, a P/E/G ratio of 2.08 and a beta of 2.37. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company’s revenue for the quarter was up 52.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.92 earnings per share. On average, research analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current year.

Insiders Place Their Bets

In other Oscar Health news, CFO Richard Scott Blackley sold 100,000 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the completion of the sale, the chief financial officer directly owned 1,216,660 shares of the company’s stock, valued at $28,177,845.60. This trade represents a 7.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Liang sold 12,475 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $273,701.50. Following the transaction, the insider owned 259,057 shares of the company’s stock, valued at approximately $5,683,710.58. This represents a 4.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 1,217,160 shares of company stock valued at $34,471,090. Insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently made changes to their positions in OSCR. Focus Partners Wealth boosted its stake in Oscar Health by 1.4% during the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after buying an additional 824 shares during the last quarter. Equitable Holdings Inc. increased its stake in Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock worth $186,000 after acquiring an additional 850 shares during the last quarter. Captrust Financial Advisors increased its stake in Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock worth $657,000 after acquiring an additional 895 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of Oscar Health by 5.6% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock worth $255,000 after acquiring an additional 938 shares in the last quarter. Finally, Binnacle Investments Inc boosted its position in shares of Oscar Health by 28.6% during the 3rd quarter. Binnacle Investments Inc now owns 4,500 shares of the company’s stock valued at $85,000 after acquiring an additional 1,000 shares during the last quarter. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.